Baicalein as a potent neuroprotective agent: A review - 14/11/17
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 12 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
In recent times, neurodegenerative diseases are the most challenging global health problems. Neuronal cell death or damage is a key factor for many neurodegenerative disorders. Therefore, there has been a growing interest in the development of effective neuroprotective agents, especially from natural sources. In particular, phytochemicals have shown high efficacy with low side effects in various in vitro and in vivo studies. In the various phytoconstituents, flavonoids are important bioactive products and mainly found in various vegetables and fruits. Among them, baicalein is one of the important flavones, which is mainly found in the root of Scutellaria baicalensis Georgi. A number of studies have reported that baicalein has potent neuroprotective properties under in vitro as well as in vivo systems. Hence, the purpose of this paper is to provide a review of the existing literature in connection with the neuroprotective effects of baicalein and its molecular mechanisms of action. The current review highlights could be useful to identify novel therapeutic agents in relation to the treatment of neurotoxicity-mediated diseases.
Le texte complet de cet article est disponible en PDF.Abbreviations : 12/15-LOX, 5-HT, 6-OHDA, AD, Akt, AMPA, APP-α, ATP, Aβ, BBB, Bcl-2, BDNF, Cav, CREB, DA, EBI, EPO, ERK, GLT-1, Gpx, GSH, GSH-px, GSK3β, H2O2, HIF1α, HO-1, HSP-70, ICH, IL-6, IL-β, iNOS, IκB, JNK, L-DOPA, LPS, LTP, MAPK, MCAO, MDA, MDCK, MMP-9, MPP+, MPTP, MRP2, NF-κB, NMDA, nNOS, NO, Nrf2, PD, PI3K, PKCα, PKC-α, PPARγ, p-γH2A.X, ROS, SAH, SNCA, SOD, TLR-4, TNF-α, TREK, VEGF
Keywords : Alzheimer’s disease, Baicalein, Neuroprotective, Parkinson’s disease, Scutellaria baicalensis
Plan
Vol 95
P. 1021-1032 - novembre 2017 Retour au numéro
Article précédent
- Current updates on microRNAs as regulators of chemoresistance
- Metin Çalışkan, Hale Güler, Vildan Bozok Çetintaş
- Molecular mechanisms of anticancer effects of Glucosamine
- Fatemeh Zahedipour, Razieh Dalirfardouei, Gholamreza Karimi, Khadijeh Jamialahmadi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?